Search - tctmd.com

Displaying 41 - 54 of 54

Sort: Relevancy | Date

News Daily News

FDA: All AFX Endovascular AAA Systems Now Under Class I Recall

L.A. McKeown

October 16, 2018

News Daily News

FDA Identifies Culprit in Endovascular Graft Type III Endoleaks

L.A. McKeown

June 19, 2018

News Features

Catheter Kerfuffle: How Concerning Is Off-Label Use in Stroke Interventions?

Todd Neale

June 21, 2017

News Daily News

HeartMate II Left Ventricular Assist System Under Recall Due to Controller Exchange Problems

Todd Neale

May 24, 2017

News Features

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Michael O'Riordan

May 08, 2017

News Daily News

Wingman35 Crossing Catheters Recalled Due to Tip Splitting, Separation

Todd Neale

May 04, 2017

News Daily News

Boston Scientific Announces Fix for Lotus Edge TAVR Device Following Implantation ‘Pause’

L.A. McKeown

January 11, 2017

News Daily News

St. Jude Medical Warns of Rapid, Unexpected, and Potentially Lethal Battery Depletions With ICDs, CRT-Ds

Shelley Wood

October 11, 2016

News Daily News

FDA: Vascu-Guard Patch Associated With Bleeding, Death After Carotid Endarterectomy

Yael L. Maxwell

September 02, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2016

Caitlin E. Cox

September 01, 2016

News Daily News

Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina

Michael O'Riordan

June 30, 2016

News Daily News

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Michael O'Riordan

June 30, 2016

News Daily News

Serious Cardiac Events, Including Death, Linked to Abuse of Antidiarrheal Medication Loperamide

Michael O'Riordan

June 08, 2016

News Daily News

Los Episodios Cardíacos Serios, incluida la Muerte se asocian a un Abuso del Fármaco Antidiarréico Lorepamida

Michael O'Riordan

June 08, 2016

Advertisement

FDA: All AFX Endovascular AAA Systems Now Under Class I Recall

FDA Identifies Culprit in Endovascular Graft Type III Endoleaks

Catheter Kerfuffle: How Concerning Is Off-Label Use in Stroke Interventions?

HeartMate II Left Ventricular Assist System Under Recall Due to Controller Exchange Problems

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Wingman35 Crossing Catheters Recalled Due to Tip Splitting, Separation

Boston Scientific Announces Fix for Lotus Edge TAVR Device Following Implantation ‘Pause’

St. Jude Medical Warns of Rapid, Unexpected, and Potentially Lethal Battery Depletions With ICDs, CRT-Ds

FDA: Vascu-Guard Patch Associated With Bleeding, Death After Carotid Endarterectomy

TCTMD’s Top 10 Most Popular Stories for August 2016

Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Serious Cardiac Events, Including Death, Linked to Abuse of Antidiarrheal Medication Loperamide

Los Episodios Cardíacos Serios, incluida la Muerte se asocian a un Abuso del Fármaco Antidiarréico Lorepamida

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content